That there is an effective cervical cancer vaccine about to hit the market is encouraging news. Any successful and safe cancer prevention method is good news. Recently, a public service announcement, PSA, has been airing on television attempting to raise awareness about the virus that can lead to cervical cancer. The PSA I am seeing is coming from Merck, one of the drug companies that will be selling the vaccine. Unless I am mistaken, not once does the PSA mention the vaccine -- only the virus associated with cervical cancer. I believe this is intentional. I believe the drug company might be anticipating a resistance from the parents of teenage daughters to the vaccine based on ethical and moral grounds. If I were a drug company, I would quickly and reasonably decide to try to keep the vaccine above the fray of ethical and moral objections by promoting education about the virus.

Vaccines are a preventative measure against virus, not a treatment for after-exposure to a virus. As such, the ideal population to reach with a cervical cancer vaccine that protects against the sexually-transmitted human papilloma virus, HPV, will be teenage girls before they become sexually active. I predict it is going to be a controversial issue and debate where sexual activity of teenage girls becomes the focal point and not the potentially life-saving cancer prevention vaccine. I am betting the current awareness-raising ad campaign from the drug company in the virus link to cervical cancer is an attempt to minimize the debate with an educational approach. That's my hunch.